Key Points
Ex vivo addition of OKT3 is an economical and easy method to prevent xenogeneic GVHD and rescue patient leukemia sample xenografts. OKT3-treated whole UCB produces robust, durable hematopoietic xenografts that are indistinguishable from CD34+ grafts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.